List of Tables
Table 1. Global Biosimilar Therapeutic Peptides Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Innovative
Table 3. Key Players of Generic
Table 4. Global Biosimilar Therapeutic Peptides Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Biosimilar Therapeutic Peptides Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Biosimilar Therapeutic Peptides Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Biosimilar Therapeutic Peptides Market Share by Region (2019-2024)
Table 8. Global Biosimilar Therapeutic Peptides Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Biosimilar Therapeutic Peptides Market Share by Region (2025-2030)
Table 10. Biosimilar Therapeutic Peptides Market Trends
Table 11. Biosimilar Therapeutic Peptides Market Drivers
Table 12. Biosimilar Therapeutic Peptides Market Challenges
Table 13. Biosimilar Therapeutic Peptides Market Restraints
Table 14. Global Biosimilar Therapeutic Peptides Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Biosimilar Therapeutic Peptides Market Share by Players (2019-2024)
Table 16. Global Top Biosimilar Therapeutic Peptides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Therapeutic Peptides as of 2023)
Table 17. Ranking of Global Top Biosimilar Therapeutic Peptides Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Biosimilar Therapeutic Peptides Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biosimilar Therapeutic Peptides Product Solution and Service
Table 21. Date of Enter into Biosimilar Therapeutic Peptides Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biosimilar Therapeutic Peptides Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Biosimilar Therapeutic Peptides Revenue Market Share by Type (2019-2024)
Table 25. Global Biosimilar Therapeutic Peptides Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Biosimilar Therapeutic Peptides Revenue Market Share by Type (2025-2030)
Table 27. Global Biosimilar Therapeutic Peptides Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Biosimilar Therapeutic Peptides Revenue Market Share by Application (2019-2024)
Table 29. Global Biosimilar Therapeutic Peptides Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Biosimilar Therapeutic Peptides Revenue Market Share by Application (2025-2030)
Table 31. North America Biosimilar Therapeutic Peptides Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Biosimilar Therapeutic Peptides Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Biosimilar Therapeutic Peptides Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Biosimilar Therapeutic Peptides Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Biosimilar Therapeutic Peptides Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Biosimilar Therapeutic Peptides Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Biosimilar Therapeutic Peptides Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Biosimilar Therapeutic Peptides Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Biosimilar Therapeutic Peptides Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Biosimilar Therapeutic Peptides Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Biosimilar Therapeutic Peptides Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Biosimilar Therapeutic Peptides Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Biosimilar Therapeutic Peptides Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Biosimilar Therapeutic Peptides Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Biosimilar Therapeutic Peptides Market Size by Country (2025-2030) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Biosimilar Therapeutic Peptides Product
Table 49. Pfizer Revenue in Biosimilar Therapeutic Peptides Business (2019-2024) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. GlaxoSmithKline Company Detail
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline Biosimilar Therapeutic Peptides Product
Table 54. GlaxoSmithKline Revenue in Biosimilar Therapeutic Peptides Business (2019-2024) & (US$ Million)
Table 55. GlaxoSmithKline Recent Development
Table 56. li Lilly and Company Company Detail
Table 57. li Lilly and Company Business Overview
Table 58. li Lilly and Company Biosimilar Therapeutic Peptides Product
Table 59. li Lilly and Company Revenue in Biosimilar Therapeutic Peptides Business (2019-2024) & (US$ Million)
Table 60. li Lilly and Company Recent Development
Table 61. Sanofi Company Detail
Table 62. Sanofi Business Overview
Table 63. Sanofi Biosimilar Therapeutic Peptides Product
Table 64. Sanofi Revenue in Biosimilar Therapeutic Peptides Business (2019-2024) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. Takeda Pharmaceuticals Company Detail
Table 67. Takeda Pharmaceuticals Business Overview
Table 68. Takeda Pharmaceuticals Biosimilar Therapeutic Peptides Product
Table 69. Takeda Pharmaceuticals Revenue in Biosimilar Therapeutic Peptides Business (2019-2024) & (US$ Million)
Table 70. Takeda Pharmaceuticals Recent Development
Table 71. Teva Pharmaceuticals Company Detail
Table 72. Teva Pharmaceuticals Business Overview
Table 73. Teva Pharmaceuticals Biosimilar Therapeutic Peptides Product
Table 74. Teva Pharmaceuticals Revenue in Biosimilar Therapeutic Peptides Business (2019-2024) & (US$ Million)
Table 75. Teva Pharmaceuticals Recent Development
Table 76. Amgen Company Detail
Table 77. Amgen Business Overview
Table 78. Amgen Biosimilar Therapeutic Peptides Product
Table 79. Amgen Revenue in Biosimilar Therapeutic Peptides Business (2019-2024) & (US$ Million)
Table 80. Amgen Recent Development
Table 81. AstraZeneca Company Detail
Table 82. AstraZeneca Business Overview
Table 83. AstraZeneca Biosimilar Therapeutic Peptides Product
Table 84. AstraZeneca Revenue in Biosimilar Therapeutic Peptides Business (2019-2024) & (US$ Million)
Table 85. AstraZeneca Recent Development
Table 86. Novartis AG Company Detail
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Biosimilar Therapeutic Peptides Product
Table 89. Novartis AG Revenue in Biosimilar Therapeutic Peptides Business (2019-2024) & (US$ Million)
Table 90. Novartis AG Recent Development
Table 91. Novo Nordisk Company Detail
Table 92. Novo Nordisk Business Overview
Table 93. Novo Nordisk Biosimilar Therapeutic Peptides Product
Table 94. Novo Nordisk Revenue in Biosimilar Therapeutic Peptides Business (2019-2024) & (US$ Million)
Table 95. Novo Nordisk Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilar Therapeutic Peptides Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Biosimilar Therapeutic Peptides Market Share by Type: 2023 VS 2030
Figure 3. Innovative Features
Figure 4. Generic Features
Figure 5. Global Biosimilar Therapeutic Peptides Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Biosimilar Therapeutic Peptides Market Share by Application: 2023 VS 2030
Figure 7. Cancer Case Studies
Figure 8. Cardiovascular Case Studies
Figure 9. Central Nervous Systems Case Studies
Figure 10. Metabolic Disorders Case Studies
Figure 11. Gastrointestinal Disorders Case Studies
Figure 12. Dermatology Case Studies
Figure 13. Others Case Studies
Figure 14. Biosimilar Therapeutic Peptides Report Years Considered
Figure 15. Global Biosimilar Therapeutic Peptides Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Biosimilar Therapeutic Peptides Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Biosimilar Therapeutic Peptides Market Share by Region: 2023 VS 2030
Figure 18. Global Biosimilar Therapeutic Peptides Market Share by Players in 2023
Figure 19. Global Top Biosimilar Therapeutic Peptides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Therapeutic Peptides as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Biosimilar Therapeutic Peptides Revenue in 2023
Figure 21. North America Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Biosimilar Therapeutic Peptides Market Share by Country (2019-2030)
Figure 23. United States Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Biosimilar Therapeutic Peptides Market Share by Country (2019-2030)
Figure 27. Germany Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Biosimilar Therapeutic Peptides Market Share by Region (2019-2030)
Figure 35. China Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Biosimilar Therapeutic Peptides Market Share by Country (2019-2030)
Figure 43. Mexico Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Biosimilar Therapeutic Peptides Market Share by Country (2019-2030)
Figure 47. Turkey Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Biosimilar Therapeutic Peptides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Pfizer Revenue Growth Rate in Biosimilar Therapeutic Peptides Business (2019-2024)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Biosimilar Therapeutic Peptides Business (2019-2024)
Figure 51. li Lilly and Company Revenue Growth Rate in Biosimilar Therapeutic Peptides Business (2019-2024)
Figure 52. Sanofi Revenue Growth Rate in Biosimilar Therapeutic Peptides Business (2019-2024)
Figure 53. Takeda Pharmaceuticals Revenue Growth Rate in Biosimilar Therapeutic Peptides Business (2019-2024)
Figure 54. Teva Pharmaceuticals Revenue Growth Rate in Biosimilar Therapeutic Peptides Business (2019-2024)
Figure 55. Amgen Revenue Growth Rate in Biosimilar Therapeutic Peptides Business (2019-2024)
Figure 56. AstraZeneca Revenue Growth Rate in Biosimilar Therapeutic Peptides Business (2019-2024)
Figure 57. Novartis AG Revenue Growth Rate in Biosimilar Therapeutic Peptides Business (2019-2024)
Figure 58. Novo Nordisk Revenue Growth Rate in Biosimilar Therapeutic Peptides Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed